Cargando…
Age‐specific differences in hypertension combination management and associated factors influencing treatment choice
The current hypertension guideline emphasizes combination therapy, especially single‐pill combination therapy (SPC). However, few studies compared the prevalence and factors associated with initial therapy choice across heterogeneous age groups in a current population. First, the authors consecutive...
Autores principales: | Xiong, Jianfei, Wang, Li, Yang, Chuanxi, Huang, Hengye, He, Ben, Shen, Lan, Su, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246461/ https://www.ncbi.nlm.nih.gov/pubmed/37196052 http://dx.doi.org/10.1111/jch.14668 |
Ejemplares similares
-
Comparison of efficacy and safety between third‐dose triple and third‐dose dual antihypertensive combination therapies in patients with hypertension
por: Sung, Ki‐Chul, et al.
Publicado: (2023) -
Efficacy and safety of co‐administered telmisartan/amlodipine and rosuvastatin in subjects with hypertension and dyslipidemia
por: Jin, Xuan, et al.
Publicado: (2020) -
Cardiovascular outcomes of β‐blocker—calcium channel blocker initial dual therapy vs. other initial dual therapies in Chinese patients with hypertension: A real‐world retrospective study
por: Lin, Junxiong, et al.
Publicado: (2023) -
Clinical effectiveness and safety of amlodipine/losartan‐based single‐pill combination therapy in patients with hypertension: Findings from real‐world, multicenter observational databases
por: Lee, Jieun, et al.
Publicado: (2021) -
An overview of the development of combined oral contraceptives containing estradiol: focus on estradiol valerate/dienogest
por: Fruzzetti, Franca, et al.
Publicado: (2012)